FDG-PET as a surrogate marker for response to Gleevec™ (imatinib mesylate) in patients with advanced gastrointestinal stromal tumors (GIST). Abstract 77. - Van den Abbeele,A.D.; Badawi,R.D.; Tetrault,R.J. (SNM, 2003)